Prognostic factors for patients with node-negative gastric cancer: Can extended lymph node dissection have a survival benefit?

Journal of Surgical Oncology

Volumn 94, Issue 1, 2006, Pages 16-20

  Park, Sung Soo ^a   Park, Joong Min ^a   Kim, Jong Han ^a   Kim, Wan Bae ^a   Lee, Juneyoung ^a   Kim, Seung Joo ^a   Kim, Chong Suk ^a   Mok, Young Jae ^a,b  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Gastric cancer; Lymph node dissection; Node negative; Prognostic factor

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STOMACH ADENOCARCINOMA; TUMOR VOLUME; UNIVARIATE ANALYSIS;

AGED; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 33745674024     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20560     Document Type: Article

References (22)

1. Siewert JR, Böttcher K, Stein HJ, et al.: Relevant prognostic factors in gastric cancer: Ten year results of the German Gastric Cancer Study. Ann Surg 1998;228:449-461.
2. Shiu MH, Perrotti M, Brennan MF: Adenocarcinoma of the stomach: A multivariate analysis of clinical, pathologic and treatment factors. Hepato-Gstroenterology 1989;36:7-12.
3. Kim JP, Kim YW, Yang HK, et al.: Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients. World J Surg 1994;18:872-877.
4. Adachi Y, Mori M, Maehara Y, et al.: Prognostic factors of node-negative gastric carcinoma: Univariate and multivariate analyses. J Am Coll Surg 1997;184:373-377.
5. Soetikno R, Gotoda T, Nakanishi Y, et al.: Endoscopic mucosal resection. Gastrointest Endosc 2003;57:567-579.
6. Shimizu S, Noshiro H, Nagai E, et al.: Laparoscopic gastric surgery in a Japanese institution: Analysis of the initial 100 procedures. J Am Coll Surg 2003;197:372-378.
7. Kim MC, Kim HH, Jung GJ, et al.: Lymphatic mapping and sentinel node biopsy using 99mTc tin colloid in gastric cancer. Ann Surg 2004;239:383-387.
8. Isozaki H, Kimura T, Tanaka N, et al.: Esophagus Gastrointestinal Surgical Treatment Study Group. An assessment of the feasibility of sentinel lymph node-guided surgery for gastric cancer. Gastric Cancer 2004;7:149-153.
9. Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma, 2nd edition. Gastric Cancer 1998;1:10-24.
10. Maehara Y, Tomoda M, Tomisaki S, et al.: Surgical treatment and outcome for node-negative gastric cancer. Surgery 1997;121:633-639.
11. Baba H, Maehara Y, Takeuchi H, et al.: Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. Surgery 1994;117:165-169.
12. Yokota T, Kunii Y Teshima S, et al.: Significant prognostic factors in patients with node-negative gastric cancer. Int Surg 1999;84:331-336.
13. Nakajima T: Gastric cancer treatment guidelines in Japan. Gastric cancer 2002;5:1-5.
14. Siewert JR, Roder JD, Böttcher K, et al.: Prognostic relevance of systemic lymph node dissection in gastric carcinoma. Br J Surg 1993;80:1015-1018.
15. Lee HK, Yang HK, Kim WH, et al.: Influence of the number of lymph nodes examined on staging of gastric cancer. Br J Surg 2001;88:1408-1412.
16. Nakamura K, Kamei T, Ohtomo N, et al.: Gastric carcinoma confined to the muscularis propria: How can we detect, evaluate, and cure intermediate-stage carcinoma of the stomach? Am J Gastroenterol 1999;94:2251-2255.
17. Ohno S, Tomisaki S, Oiwa H, et al.: Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach. J Am Coll Surg 1995;180:577-582.
18. Harrison LE, Karpeh MS, Brennan MF: Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer. J Gastrointest Surg 1998;2:126-131.
19. Feinstein AR, Sobin DM, Wells CK: The Will Rogers phenomenon: Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. New Engl J Med 1985;312:1604-1608.
20. Cuschieri A, Weeden S, Fielding J, et al.: Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial. Br J Cancer 1999;79:1522-1530.
21. Bonenkamp JJ, Hermans J, Sasoko M, et al.: Extended lymphnode dissection for gastric cancer. New Engl J Med 1999;340:908-914.
22. Kikuchi Y, Tsuchiya A, Ando Y, et al.: Immunohistochemical detection of lymph node microinvolvement in node-negative gastric cancer. Gastric Cancer 1999;2:173-178.